Talk:Ramoplanin

This is the talk page for discussing improvements to the Ramoplanin article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ramoplanin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Is it a lipoglycopeptide ?[edit]

Intro says it is a glycolipodepsipeptide. Is it therefore a lipoglycopeptide ? Rod57 (talk) 14:50, 21 March 2010 (UTC)[reply]

Probably not, given the title of "Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy, Curr Opin Investig Drugs. 2006 Aug;7(8):740-9;". - Rod57 (talk) 12:51, 6 April 2013 (UTC)[reply]

Need a History section[edit]

Oldest reference used is 2005. - Rod57 (talk) 12:47, 6 April 2013 (UTC)[reply]

Errors in Ramoplanin[edit]

The formula given is for Ramoplanin A2 aglycone and the structural formula is for Ramoplanin A2 (C119H154ClN21O40). The aglycone part of the structural formula is missing an oxygen and a chlorine. I think the rightmost phenyl group should have a hydroxy para to the attachment point and a chlorine meta. Osterhou (talk) 18:06, 13 April 2013 (UTC)[reply]

Proposed merge of Draft:Ramoplanin into Ramoplanin[edit]

Draft contains more detail, and should be folded in. Robert McClenon (talk) 18:35, 4 June 2022 (UTC)[reply]

Done Artoria 2e5 🌉 02:19, 16 September 2022 (UTC)[reply]